Eurofins debuts real-time RT-PCR test for COVID-19

LabPulse.com staff writers
May 7, 2020
2020 03 18 20 13 7386 Virus Coronavirus Covid 19 400

Eurofins Technologies has announced the launch of a multiplex real-time reverse transcription polymerase chain reaction (RT-PCR) test for the novel coronavirus.

The GSD NovaPrime SARS-CoV-2 assay identifies two target sequences inside the coronavirus's N gene. The test provides results in about two hours and includes an extraction and inhibition control and positive control, the diagnostic technologies provider said in a statement.

Eurofins affiliate companies Gold Standard Diagnostics, Virotech Diagnostics, and NovaTec Immundiagnostica led the development of the PCR assay. Eurofins previously launched enzyme-linked immunosorbent assay (ELISA) kits with the CE-IVD Mark for detection of coronavirus antibodies in April.

Latest in PCR
Bacteria Blood Sepsis Social
Nonprofit health system adopts Immunexpress test for detecting sepsis
August 23, 2023
Latest in at-home or lab-based STI testing
Sponsored
Latest in at-home or lab-based STI testing
September 28, 2023
Bladder Urinary 3 D Social
Studies show Pathnostics UTI test required fewer resources, reduced costs compared to standard testing
June 20, 2023
Lab Woman Dna Social
Roche receives WHO prequalification for HPV screening tool
June 13, 2023
Related Stories
Woman Mask Anxiety Covid Resized
COVID-19
Eurofins launches droplet digital PCR assay to detect SARS-CoV-2 variants of concern in wastewater
2020 04 21 18 40 7882 Rna Genome 400
Sequencing
Eurofins debuts new SARS-CoV-2 variant assay
2020 03 18 20 13 7386 Virus Coronavirus Covid 19 400
COVID-19
Eurofins debuts 2 products to test for COVID-19
Latest in at-home or lab-based STI testing
Sponsor Content
Latest in at-home or lab-based STI testing
More in PCR
Nonprofit health system adopts Immunexpress test for detecting sepsis
FirstHealth of the Carolinas, a nonprofit health system licensed for four hospitals in North Carolina, will use Immunexpress’ SeptiCyte Rapid test to help differentiate sepsis-positive cases from patients with infection-negative systemic inflammation.
August 23, 2023
Bacteria Blood Sepsis Social
ChromaCode starts early-access launch of lung cancer variant test
The test is designed to address diagnostic problems that prevent patients from undergoing timely cancer biomarker testing and receiving targeted therapies.
August 15, 2023
Lung Cancer Hotspot Social
Studies show Pathnostics UTI test required fewer resources, reduced costs compared to standard testing
In the study, the average one-year costs related to UTIs were $501.85 lower for patients receiving treatment based on the Guidance test than for those receiving treatment based on the traditional culture test.
June 20, 2023
Bladder Urinary 3 D Social
Roche receives WHO prequalification for HPV screening tool
Prequalification helps expand access to the screening tool in countries that rely on the WHO's list of prequalified suppliers in making purchasing and implementation decisions.
June 13, 2023
Lab Woman Dna Social
Eurobio Scientific obtains IVDR CE markings for PCR tests
The CE markings enable the firm to market three of its PCR tests as class C in vitro diagnostic medical devices for the detection of infectious diseases.
May 24, 2023
Business Regulation Graphic Social Resized
A. Menarini launches full automated MDx platform at WorldLab-EuroMedLab
The system, Prime MDx, is an all-in-one, sample-to-result platform designed to allows users to process a variety of sample types through real-time polymerase chain reaction (PCR), the Florence, Italy-based firm said.
May 23, 2023
Artificial Intelligence Ai Social
BioMĂ©rieux receives FDA CLIA waiver for multiplex PCR respiratory panel
In about 15 minutes, the panel detects five of the most common viral causes of upper respiratory tract infections: SARS-CoV-2, influenza A, influenza B, respiratory syncytial virus (RSV), and rhinovirus.
May 11, 2023
Patient Doctor Women Social
Bio-Rad Laboratories Q1 net sales drop 3%; firm lowers full-year guidance
Bio-Rad shares were down on Friday, a day after the firm updated its financial outlook for full-year 2023; it anticipates non-GAAP currency-neutral revenue growth of approximately 4.5% compared to its previous estimate of 6% to 7%.
May 5, 2023
Business Financial Results Social
Qiagen launching syndromic molecular diagnostic system with respiratory panel in Japan
Qiagen said Monday that its QIAstat-Dx syndromic testing system is expected to be available soon in Japan with a SARS-CoV-2 Respiratory Panel that can detect more than 20 pathogens from a patient sample.
April 24, 2023
Women Laboratory Social
Curative spins off Sensible Diagnostics to commercialize point-of-care PCR platform
The spin-off is utilizing the experience Curative has gained with its diagnostics business during the pandemic, having run more than two million molecular point-of-care COVID-19 tests.
April 24, 2023
Blood Test Samples Lab Social
Seegene collaborates with Hy Laboratories, seeks similar deals to broaden syndromic testing
Embracing an open innovation model, the company is seeking leading companies to join a collaborative network and collectively develop hundreds, or more, of syndromic PCR assays annually to serve both local and global markets.
March 28, 2023
Covid 19 Global Financial Crisis Social
Long COVID less likely after Omicron than after original virus, Swiss researchers find
In a Swiss study, investigators have found that long COVID is less likely after Omicron infection than after infection by the original wild-type SARS-CoV-2 virus.
March 9, 2023
Covid Treatment Doctor Social
Page 1 of 22
Next Page